XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Business Segment Information
3 Months Ended
Mar. 31, 2021
Business Segment Information  
Business Segment Information

NOTE C—Business Segment Information

The accounting policies of the Company’s segments are the same as those described in Note A—“General.” The Company evaluates performance of its segments based on profit or loss from operations before stock compensation expense, depreciation and amortization, interest expense, interest and other income, changes in the fair value of contingent consideration recorded in relation to acquisitions, gain on sale of assets, special charges or benefits, and income taxes (“Segment Profit”). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Healthcare subcontracts with Pharmacy Management to provide pharmacy benefits management services for certain of Healthcare’s customers. In addition, Pharmacy Management provides pharmacy benefits management for the Company’s employees covered under its medical plan. As

such, revenue, cost of goods sold and direct service costs and other related to these arrangements are eliminated. The Company’s segments are defined in Note A—“General.”

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

    

    

    

Corporate

    

 

Pharmacy

and

 

Healthcare

Management

Elimination

Consolidated

 

Three Months Ended March 31, 2020

Managed care and other revenue

$

488,906

$

64,435

$

(173)

$

553,168

PBM revenue

 

 

573,778

 

(4,567)

 

569,211

Cost of care

 

(349,108)

 

 

 

(349,108)

Cost of goods sold

 

 

(537,574)

 

4,333

 

(533,241)

Direct service costs and other

 

(105,936)

 

(81,866)

 

(16,439)

 

(204,241)

Stock compensation expense (1)

 

1,761

 

2,107

 

1,929

 

5,797

Segment Profit (Loss)

$

35,623

$

20,880

$

(14,917)

$

41,586

    

    

    

Corporate

    

 

Pharmacy

and

 

Healthcare

Management

Elimination

Consolidated

 

Three Months Ended March 31, 2021

Managed care and other revenue

$

533,010

$

93,227

$

(161)

$

626,076

PBM revenue

 

 

538,972

 

(3,399)

 

535,573

Cost of care

 

(379,191)

 

 

 

(379,191)

Cost of goods sold

 

 

(495,593)

 

3,223

 

(492,370)

Direct service costs and other

 

(114,993)

 

(104,596)

 

(11,432)

 

(231,021)

Legal matter settlement

9,000

9,000

Stock compensation expense (1)

 

2,519

 

2,696

 

1,842

 

7,057

Segment Profit (Loss)

$

41,345

$

43,706

$

(9,927)

$

75,124

(1)Stock compensation expense, changes in the fair value of contingent consideration recorded in relation to acquisitions and impairment of intangible assets are included in direct service costs and other operating expenses; however, these amounts are excluded from the computation of Segment Profit.

The following table reconciles income from continuing operations before income taxes to Segment Profit from continuing operations (in thousands):

Three Months Ended

March 31, 

    

2020

    

2021

Income from continuing operations before income taxes

$

4,692

$

39,414

Stock compensation expense

 

5,797

 

7,057

Depreciation and amortization

 

23,358

 

21,417

Interest expense

 

8,958

 

6,426

Interest and other income

 

(1,219)

 

(341)

Special charges

1,151

Segment Profit from continuing operations

$

41,586

$

75,124